ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ

Johannes Breyer,Wolfgang Otto,Ralph M. Wirtz,Bernd Wullich,Bastian Keck,Philipp Erben,Maximilian C. Kriegmair,Robert Stoehr,Markus Eckstein,Mark Laible,Kornelia Schlombs,Sebastian Eidt,Stefan Denzinger,Maximilian Burger,Arndt Hartmann

ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ

2017

Johannes Breyer
Wolfgang Otto
Ralph M. Wirtz
Bernd Wullich
Bastian Keck
Philipp Erben
Maximilian C. Kriegmair
Robert Stoehr
Markus Eckstein
Mark Laible
Kornelia Schlombs
Sebastian Eidt
Stefan Denzinger
Maximilian Burger
Arndt Hartmann

Background/Aims/Objectives: It is difficult to identify patients with a non-muscle-invasive bladder cancer (NMIBC) at stage pT1 with concomitant carcinoma in situ

Keywords:

Urology
Carcinoma in situ
Medicine
Cystectomy
Bladder cancer
in patient
potential risk
Internal medicine
Concomitant
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations